Asarat et al. treated IBD mice with butyric acid and found that their plasma IL-6 levels were lower compared to the model group, indicating that butyric acid suppressed the expression of inflammatory factors in the treatment of IBD (Asarat et al., 2016). The gene discussed is IL6; the disease is irritable bowel syndrome.